Kalsoom S, Rasool M, Imran I, Saeed H, Ahmad T, Alqahtani F
Pharmaceuticals (Basel). 2024; 17(2).
PMID: 38399480
PMC: 10891759.
DOI: 10.3390/ph17020265.
Kus M, Ibragimow I, Piotrowska-Kempisty H
Pharmaceutics. 2023; 15(11).
PMID: 38004503
PMC: 10674574.
DOI: 10.3390/pharmaceutics15112523.
Habiballah S, Reisfeld B
Sci Rep. 2023; 13(1):14934.
PMID: 37696914
PMC: 10495394.
DOI: 10.1038/s41598-023-42165-3.
Sahoo D, Martinez M, Dao K, Gabriel V, Zdyrski C, Jergens A
Cells. 2023; 12(9).
PMID: 37174669
PMC: 10177590.
DOI: 10.3390/cells12091269.
Muschong P, Jin L, Schejbal J, Mezler M, Weinheimer M
Pharm Res. 2023; 40(5):1259-1270.
PMID: 36977814
DOI: 10.1007/s11095-023-03490-4.
Inkjet drug printing onto contact lenses: Deposition optimisation and non-invasive dose verification.
Pollard T, Seoane-Viano I, Ong J, Januskaite P, Awwad S, Orlu M
Int J Pharm X. 2023; 5:100150.
PMID: 36593987
PMC: 9804110.
DOI: 10.1016/j.ijpx.2022.100150.
Drug Physicochemical Properties and Capsule Fill Determine Extent of Premature Gastric Release from Enteric Capsules.
Moghrabi F, Fadda H
Pharmaceutics. 2022; 14(11).
PMID: 36432696
PMC: 9695824.
DOI: 10.3390/pharmaceutics14112505.
Tailoring of Rosuvastatin Calcium and Atenolol Bilayer Tablets for the Management of Hyperlipidemia Associated with Hypertension: A Preclinical Study.
Elsayed M, Aboelez M, Mohamed M, Mahmoud R, El-Shenawy A, Mahmoud E
Pharmaceutics. 2022; 14(8).
PMID: 36015255
PMC: 9412892.
DOI: 10.3390/pharmaceutics14081629.
Investigating Halloysite Nanotubes as a Potential Platform for Oral Modified Delivery of Different BCS Class Drugs: Characterization, Optimization, and Evaluation of Drug Release Kinetics.
Husain T, Shoaib M, Ahmed F, Yousuf R, Farooqi S, Siddiqui F
Int J Nanomedicine. 2021; 16:1725-1741.
PMID: 33688188
PMC: 7935346.
DOI: 10.2147/IJN.S299261.
Effect of lipid and cellulose based matrix former on the release of highly soluble drug from extruded/spheronized, sintered and compacted pellets.
Maboos M, Yousuf R, Shoaib M, Nasiri I, Hussain T, Ahmed H
Lipids Health Dis. 2018; 17(1):136.
PMID: 29885655
PMC: 5994249.
DOI: 10.1186/s12944-018-0783-8.
Functional selectivity of GPCR-directed drug action through location bias.
Irannejad R, Pessino V, Mika D, Huang B, Wedegaertner P, Conti M
Nat Chem Biol. 2017; 13(7):799-806.
PMID: 28553949
PMC: 5733145.
DOI: 10.1038/nchembio.2389.
Predictive Performance of Physiologically Based Pharmacokinetic and Population Pharmacokinetic Modeling of Renally Cleared Drugs in Children.
Zhou W, Johnson T, Xu H, Cheung S, Bui K, Li J
CPT Pharmacometrics Syst Pharmacol. 2016; 5(9):475-83.
PMID: 27566992
PMC: 5036422.
DOI: 10.1002/psp4.12101.
Exploring the Feasibility of Biowaiver Extension of BCS Class III Drugs with Site-Specific Absorption Using Gastrointestinal Simulation Technology.
Sun L, Sun J, He Z
Eur J Drug Metab Pharmacokinet. 2016; 42(3):471-487.
PMID: 27447171
DOI: 10.1007/s13318-016-0361-2.
Using Physiologically Based Pharmacokinetic (PBPK) Modelling to Gain Insights into the Effect of Physiological Factors on Oral Absorption in Paediatric Populations.
Villiger A, Stillhart C, Parrott N, Kuentz M
AAPS J. 2016; 18(4):933-47.
PMID: 27060007
DOI: 10.1208/s12248-016-9896-z.
The Effect of Excipients on the Permeability of BCS Class III Compounds and Implications for Biowaivers.
Parr A, Hidalgo I, Bode C, Brown W, Yazdanian M, Gonzalez M
Pharm Res. 2015; 33(1):167-76.
PMID: 26286187
PMC: 4689772.
DOI: 10.1007/s11095-015-1773-4.
Similarities and differences in gastrointestinal physiology between neonates and adults: a physiologically based pharmacokinetic modeling perspective.
Yu G, Zheng Q, Li G
AAPS J. 2014; 16(6):1162-6.
PMID: 25182208
PMC: 4389743.
DOI: 10.1208/s12248-014-9652-1.
Physiologically based pharmacokinetic models in the prediction of oral drug exposure over the entire pediatric age range-sotalol as a model drug.
Khalil F, Laer S
AAPS J. 2014; 16(2):226-39.
PMID: 24399240
PMC: 3933580.
DOI: 10.1208/s12248-013-9555-6.
Drug discovery and regulatory considerations for improving in silico and in vitro predictions that use Caco-2 as a surrogate for human intestinal permeability measurements.
Larregieu C, Benet L
AAPS J. 2013; 15(2):483-97.
PMID: 23344793
PMC: 3675726.
DOI: 10.1208/s12248-013-9456-8.
Comparison of the permeability of metoprolol and labetalol in rat, mouse, and Caco-2 cells: use as a reference standard for BCS classification.
Incecayir T, Tsume Y, Amidon G
Mol Pharm. 2013; 10(3):958-66.
PMID: 23327720
PMC: 3605724.
DOI: 10.1021/mp300410n.
The role of BCS (biopharmaceutics classification system) and BDDCS (biopharmaceutics drug disposition classification system) in drug development.
Benet L
J Pharm Sci. 2012; 102(1):34-42.
PMID: 23147500
PMC: 3684558.
DOI: 10.1002/jps.23359.